There is a lack of early translational funding and technical support for new product developers to move beyond the idea stage and into the product development space.
Establishing a technical development center (or centers) will assist researchers developing new digital therapeutics for SUD.
These
credit:
centers will provide idea developers with technical development support to prepare the PI for future funding applications (e.g.
Phase I SBIR, other NIH research grants, Blueprint Neurotherapeutics or Blueprint MedTech, etc.).
The technical development assistance will include support from experts in the idea to product translation activities including the following:
target product profile development clinical need assessment project plan development with timeline and milestones prototype development proof-of-concept study design preliminary safety assessments assistance in understanding current and future regulatory requirements